Metastasis from Gastric Carcinoma Causing Ureteral Obstruction by Yee, Lee Fei et al.
Yee et al                                     Secondary bladder adenocarcinoma 
 
Vol 3 Issue 2 Apr – Jun 2017                                                        Indian J Case Reports / 50 
Case Report 
Metastasis from Gastric Carcinoma Causing Ureteral Obstruction 
Lee Fei Yee, FamXeng Inn, Guan Hee Tan, Eng Hong Goh, Praveen Singam 
From, the Department of General Surgery, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre (UKMMC), 
Kuala Lumpur, Malaysia. 
Correspondence to: Dr Lee Fei Yee, surgery trainee lecturer, Principal contact for editorial correspondence, Malaysia. Email: 
drleefy@gmail.com 
Received: 10 Feb 2017    Initial Review: 20 Feb 2017    Accepted:  28 Feb 2017         Published Online: 04 Apr 2017 
ABSTRACT 
Gastric carcinoma rarely metastasizes to the lower urinary tract. Adenocarcinomas are commonly found in the stomach, 
however this histologic entity is rarely seen in the bladder and often difficult to distinguish primary from secondary with only 
histopathologic changes. We report a 61 year old man with a history of total gastrectomy for gastric adenocarcinoma 
presenting six months later with metastasis to the lower urinary tract. He presented with nonspecific symptoms and laboratory 
investigations showed progressive elevation of serum creatinine level. Despite implantation of double J stents, renal function 
did not improve. Computed tomography revealed enlarged mesenteric lymph node, bilateral hydronephrosis and hydroureter 
likely due to bladder wall thickening at the vesicoureteric junction. Retrograde pyelogram and biopsies taken from the bladder 
revealed secondary bladder adenocarcinoma. In summary, metastatic carcinoma of the lower urinary tract should be considered 
in patients with history of gastric adenocarcinoma whose presentation is consistent with ureteral obstruction. 
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rimary bladder cancer (BC) is a common urological 
malignancy. Histologically, 95% of cases are 
transitional cell carcinoma while secondary BC is 
responsible for less than 2% of all BC. Adenocarcinoma of 
the bladder accounts for only 1% and most cases are seen 
as a result of metastatic involvement. Metastatic 
adenocarcinoma has an aggressive clinical course and the 
prognosis is always poor. It is not possible to obtain cure 
with surgery, however chemotherapy and radiotherapy 
may be administered for palliative purposes [1]. 
Therefore, when bladder adenocarcinoma is 
encountered, primary cause should be distinguished from 
secondary BC because their treatment and prognosis 
differs. We report a case presenting with nonspecific 
symptoms and found to have bladder metastasis secondary 
to gastric adenocarcinoma. 
 
CASE REPORT 
A 61-year-old man, with a history of total gastrectomy and 
adjuvant chemotherapy 6 months prior for a gastric 
adenocarcinoma (T4aN3bM0); presented to us with 
abdominal discomfort and early satiety of 2 weeks 
duration. There were neither urinary symptoms nor 
significant weight loss. He denied smoking and alcohol 
consumption. Clinical examination was unremarkable at 
that time. 
The initial blood results were within normal limits 
apart from deranged renal function (urea 18.6mmol/L and 
creatinine 899µmol/L). Abdominal ultrasound showed 
mild bilateral hydronephrosis with presence of free fluid in 
the abdominal cavity. Despite adequate hydration, the 
renal function progressively worsened and required 
hemodialysis.  
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Figures: Fig 1 A & B - CT scan demonstrate urinary bladder thickening at both vesicoureteric junction (thicker on the right), 
Fig 2 - Microscopic appearance of poorly differentiated cells on hematoxylin and eosin stain  
        
Figures: Fig 3 - Large cells with nuclear pleomorphism, inconspicuous nucleoli and presence of cytoplasmic mucin (PAS 
positive, Diastase resistant), Fig 4 - Atypical cells stained positive to CK 7, Fig 5 - Atypical cells stained positive to CK20. 
Computed tomography (CT) of the abdomen showed 
urinary bladder thickening at both vesicoureteric junction 
(VUJ) causing bilateral hydroureteronephrosis (Fig 1 A & 
B). Bilateral nephrostomy tube was inserted and the renal 
function improved. Retrograde pyelogram (RPG) 
demonstrated bilateral distal ureteric strictures up to mid-
ureter with moderate hydroureteronephrosis proximally. 
There was also a thickened and irregular area seen at the 
right ureteric orifice extending to the lateral bladder wall. 
These suspicious lesions were biopsied and double J stents 
were inserted bilaterally. He was discharged home well a 
month later. 
Histopathologic examination of the material collected 
from the bladder lesion demonstrated poorly differentiated 
adenocarcinoma (Fig 2), similar to the primary gastric 
carcinoma of the patient. There were typical cells 
infiltration within the stroma with nuclear pleomorphism, 
inconspicuous nucleoli and presence of cytoplasmic mucin 
(PAS positive, diastase resistant) (Fig 3). The covering 
urothelium forms Brunn’s nest in areas and the epithelial 
cells display small round nuclei with ample amount of 
eosinophiliccytoplasm. Imunohistochemical analysis 
showed atypical cells immunoreactivity to CK7 and CK20 
(Fig 4 & 5). 
The microsection of the stomach showed an extensive 
infiltrating poorly differentiated adenocarcinoma with full 
thickness wall invasion and infiltration into the 
surrounding fibroadipose tissue including serosal margin. 
There is perineural invasion observed as well. Both 
proximal and distal margins are clear of tumor. A total of 
23 out of 25 paragastric lymph nodes with lymphovascular 
permeation by the tumor were seen.  
Unfortunately, he presented again 2 weeks after 
discharge with abdominal distension, progressive weight 
loss, poor oral intake and a painless lesion in the 
umbilicus. On examination, he was emaciated and there 
was an umbilical lesion measuring 2x2cm. It was painless, 
hard and not adherent to the underlying structure, likely to 
represent Sister Mary Joseph’s nodules. 
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During oesophagogastroduodenoscopy, the scope 
could only advance up to 50cm from the incisor. Repeated 
CT scan showed stricture at the oesophago-jejunal 
anastomotic site with proximal oesophageal dilatation and 
worsening ascites in the abdominal cavity. The clinical 
condition of the patient indicated that the disease has 
progressed rapidly over a short period of time. He is now 
under palliative care.  
DISCUSSION 
The incidence of secondary BC is comparable to the non-
transitional cell primary carcinoma [2]. They may spread 
by direct extension from surrounding organs (colon, 
rectum, prostate and cervix) or distant metastasis by 
lymphatic, hematogenous or peritoneal dissemination and 
metastasis arising from stomach was reported 
approximately 4% [3]. 
Secondary BC rarely give rise to urinary symptoms 
before the primary site is detected. They have reported 
many cases were found incidentally at autopsy [4]. 85% of 
patients remained asymptomatic, however the most 
frequent presentation include flank pain (15-50%) and 
hematuria (16%) [4]. It is extremely rare to find 
obstructive uropathy as the first sign of gastric metastasis; 
may be due to bladder tumor involving the VUJ or 
microinvolvement of the ureter by metastasiswhich both 
are seen in our patient.  It has been reported there are 3 
different types of ureteral involvement-periureteral 
adventitial layer infiltrated by tumor cells, transmural or 
submucosal involvements [4]. 
Base on the RPG findings of this patient, the tumor 
were seen at the VUJ extending up to mid-ureter. We were 
unable to confirm if there is transmuralinvolvement based 
on the RPG findings and biopsy of the mucosa of the 
bladder wall unless resection is performed.  According to 
the HPE reports of our patient, there is lymphatic and 
venous invasion into the paragastric lymph nodes 
suggesting that the metastasis occurred via lymphatic and 
hematogenous route. 
The presentation of umbilical nodules in a patient with 
known malignancy should be evaluated as cutaneous 
metastasis. It was reported as rare presentation and 
represent only 10% of all secondary tumors which have 
spread to the skin [5]. This usually indicates advanced 
neoplastic disease with poor prognosis and generally 
inoperable. 
Primary adenocarcinoma of the bladder is relatively 
rare and this commonly causes dilemma to differentiate 
them from secondary process. Mastofi have reported [6] 
the histological characteristics that may suggest primary 
origin, that include the presence of polypoid formation, 
Brunn's nests or glandular or mucous metaplasia within the 
adjacent mucosa and foci of other epithelial tumor cells 
such as squamous or transitional cells. However in the 
presence of gastrointestinal adenocarcinoma, the author 
has been reluctant to classify the bladder tumor as primary 
disease [6]. 
On the other hand, Bates states [2] that if tumor was 
seen to be infiltrated from adjacent organs (direct spread), 
histological appearance of the bladder tumor was 
comparable to the primary tumor of other site or tumor 
appeared histologically incompatible with origin from the 
bladder are accepted as secondary malignancy. In addition, 
secondary tumor deposits were almost always solitary 
(96.7%), and 54% were located in the bladder neck or 
trigone [2]. 
Early diagnosis of secondary bladder carcinoma often 
posed a challenge to physicians as they may remained 
undetected until it become extensive as to prevent 
complete removal and due to its rare entity. It has been 
demonstrated that urine sample for cytology is sufficient to 
diagnose secondary bladder cancer [7]. Therefore, urine 
sample should be collected and to be evaluated for 
cytology in patients with subtle changes in urinary 
symptoms or in laboratory values for early detection. 
Specimen obtained directly from the suspicious site should 
be done for diagnostic purposes. 
All umbilical nodules should be biopsied to determine 
the pathological nature of the lesions. It was stated that 
75% these cutaneous lesions correspond to a "Sister 
Joseph's nodule [8].Metastatic bladder from gastric 
adenocarcinoma with the presence of Sister Mary nodules 
has a very unfavorable prognosis. 75% of the patients die 
within 6 months after onset of symptoms of ureteral 
obstruction [9]. It is difficult to alter the course of the 
disease even with aggressive adjuvant therapy or surgical 
intervention in such rapidly progressed disease. Therefore, 
in view of the course of the disease observed in our 
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patient, there were no biopsies taken from the umbilical 
lesion. 
CONCLUSION 
Lower urinary tract metastases are extremely infrequent in 
the natural history of this disease. There must be high 
index of suspicion when a patient who has malignant 
disease has evidence of ureteral obstruction on laboratory 
or radiographic studies. The presence of lower urinary 
tract metastases in addition to Sister Mary Joseph nodules 
indicates advanced disease. The prognosis is usually poor 
even with aggressive neo-adjuvant therapy and surgery. 
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